-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Mwa9WKwh8rT/kxZJrCRSnzcCAhj5EkgZjmf60Om9scJE6MI9SPtvOT2ozAS2VHoW xzTruqb9HgRNn4zfIaD3Ew== 0001019687-10-002862.txt : 20100803 0001019687-10-002862.hdr.sgml : 20100803 20100802200654 ACCESSION NUMBER: 0001019687-10-002862 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100802 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100803 DATE AS OF CHANGE: 20100802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AETHLON MEDICAL INC CENTRAL INDEX KEY: 0000882291 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 133632859 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21846 FILM NUMBER: 10985460 BUSINESS ADDRESS: STREET 1: 8910 UNIVERSITY CENTER LANE #660 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-459-7800 MAIL ADDRESS: STREET 1: 8910 UNIVERSITY CENTER LANE #660 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: BISHOP EQUITIES INC DATE OF NAME CHANGE: 19930602 8-K 1 aethlon_8k-0802210.htm CURRENT REPORT ON FORM 8-K aethlon_8k-0802210.htm
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): August 2, 2010
 
AETHLON MEDICAL, INC.
(Exact name of registrant as specified in its charter)
         
Nevada
(State or other jurisdiction
of incorporation)
  
000-21846
(Commission File Number)
  
13-3632859
(IRS Employer
Identification Number)

     
8910 University Center Lane, Suite 660
San Diego, California
(Address of principal executive offices)
  
92122
(Zip Code)

 
Registrant’s telephone number, including area code: (858) 459-7800

Not applicable
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
     
o
  
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
o
  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
o
  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
o
  
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 
 
 


ITEM 8.01
OTHER EVENTS.

On August 2, 2010, Aethlon Medical, Inc. (the “Company”) filed two registration statements on Form S-­8 (the “S-8s”) with the Securities and Exchange Commission (the “Commission”) covering an aggregate of 20,916,060 shares of the common stock of the Company. Of the shares of common stock registered under the S-8s, all but 3,500,000 shares are for currently outstanding option and share grants, some dating back to 2001. The remaining 3,500,000 shares registered under the S-8s will be available for issuance by the Company under its newly adopted 2010 Stock Incentive Plan.

The summary above is qualified in its entirety by reference to the S-8s filed with the Commission, which are incorporated herein by this reference.


ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS.
 
(d) EXHIBITS
   
EXHIBIT NO.
DESCRIPTION
99.1
Registration Statement on Form S-8 (File No. 333-168481) filed with the Securities and Exchange Commission on August 2, 2010 (incorporated by reference to such filing)
99.2
Registration Statement on Form S-8 (File No. 333-168483) filed with the Securities and Exchange Commission on August 2, 2010 (incorporated by reference to such filing)


 
 
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
       
 AETHLON MEDICAL, INC.
         
       
 
By: /s/ James A. Joyce                                                      
       
James A. Joyce
   
Dated: August 2, 2010
  
Chief Executive Officer
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 

EXHIBIT INDEX

EXHIBIT NO.
DESCRIPTION
99.1
Registration Statement on Form S-8 (File No. 333-168481) filed with the Securities and Exchange Commission on August 2, 2010 (incorporated by reference to such filing)
99.2
Registration Statement on Form S-8 (File No. 333-168483) filed with the Securities and Exchange Commission on August 2, 2010 (incorporated by reference to such filing)


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-----END PRIVACY-ENHANCED MESSAGE-----